Myeloma Trial, Recruiting NCT05640843 Sponsor: Memorial Sloan Kettering Cancer Center Condition: Myeloma
Back to Myeloma

Myeloma Trial, Recruiting

NCT05640843
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with MGUS (Monoclonal Gammopathy of Undetermined Significance) or SMM (Smoldering Multiple Myeloma).
  • People with a non-light chain type of MGUS or SMM where certain protein levels in the blood or bone marrow meet specific thresholds (confirm with trial site).
  • People with a light chain type of MGUS or SMM where certain protein levels in the blood or bone marrow meet specific thresholds (confirm with trial site).
  • People with an IgA type of MGUS or SMM where IgA levels and a specific blood test result meet certain values (confirm with trial site).
  • People with an IgD type of MGUS or SMM where IgD levels and a specific blood test result meet certain values (confirm with trial site).
  • People aged 18 years or older.
  • People who are willing to follow all study procedures throughout the trial.
  • People who are generally able to carry out daily activities, ranging from fully active to limited self-care (a medical assessment will determine this).
  • People who have an interest in learning to cook plant-based recipes.

Who may not be able to join:

  • People who already follow a whole foods, plant-based diet (note: ovo-lacto-vegetarian diets or processed vegan diets do not disqualify someone).
  • People who have an allergy to legumes (such as beans, lentils, or chickpeas).
  • People who have a severe allergy to certain nuts, specifically cashews, such as a history of anaphylactic shock.
  • People who are currently taking part in a weight loss, dietary, or exercise program.
  • People whose mental health would prevent them from being able to participate fully in the study.
  • People who are currently enrolled in, or have been enrolled in, another investigational treatment study within the past 180 days.
  • People who are currently pregnant.
  • People who test positive for Hepatitis B, Hepatitis C, or HIV, unless the infection has been treated and the virus is no longer detectable in the blood.
  • People who have certain abnormal electrolyte (blood salt) levels that have not yet been corrected (confirm with trial site).
  • People where the trial doctor has concerns about their ability to safely complete the study or where there may be other medical reasons making participation unsuitable.
  • People who drink heavily, defined as more than 2 alcoholic drinks per day or more than 14 per week.
  • People who currently use illicit drugs such as heroin or cocaine (marijuana does not disqualify someone).
  • People who have plans for extended travel during the study that would make it difficult to follow the required diet.
  • People who have had major gastrointestinal surgery within the past 3 months (removal of the appendix or gallbladder does not disqualify someone).
  • People who are currently taking curcumin or omega-3 supplements and are not willing to stop taking them from the time of signing the trial consent form.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Urvi A Shah, MD, MS, Memorial Sloan Kettering Cancer Center

Phone: 646-608-3713

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
29 November 2022
Est. completion
1 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Stool microbiome diversity at 12 weeks

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov